975 related articles for article (PubMed ID: 21712506)
61. Heparin monitoring during coronary intervention: activated clotting time versus activated partial thromboplastin time.
Nath FC; Muller DW; Rosenschein U; Ellis SG; Topol EJ
Can J Cardiol; 1993 Nov; 9(9):797-801. PubMed ID: 8281479
[TBL] [Abstract][Full Text] [Related]
62. Transitioning hospitalized patients from rivaroxaban or apixaban to a continuous unfractionated heparin infusion: A retrospective review.
Smith AR; Dager WE; Gulseth MP
Am J Health Syst Pharm; 2020 Aug; 77(Suppl 3):S59-S65. PubMed ID: 32719867
[TBL] [Abstract][Full Text] [Related]
63. Enoxaparin anticoagulation monitoring in the catheterization laboratory using a new bedside test.
Silvain J; Beygui F; Ankri A; Bellemain-Appaix A; Pena A; Barthelemy O; Cayla G; Gallois V; Galier S; Costagliola D; Collet JP; Montalescot G
J Am Coll Cardiol; 2010 Feb; 55(7):617-25. PubMed ID: 20170785
[TBL] [Abstract][Full Text] [Related]
64. Computer-assisted dosing of heparin. Management with a pharmacy-based anticoagulation service.
Kershaw B; White RH; Mungall D; Van Houten J; Brettfeld S
Arch Intern Med; 1994 May; 154(9):1005-11. PubMed ID: 8179443
[TBL] [Abstract][Full Text] [Related]
65. Correlation Among Antifactor Xa, Activated Partial Thromboplastin Time, and Heparin Dose and Association with Pediatric Extracorporeal Membrane Oxygenation Complications.
McMichael ABV; Hornik CP; Hupp SR; Gordon SE; Ozment CP
ASAIO J; 2020 Mar; 66(3):307-313. PubMed ID: 30883406
[TBL] [Abstract][Full Text] [Related]
66. Evaluation of safety and effectiveness of standardized antifactor Xa-based unfractionated heparin protocols in obese versus non-obese patients.
Isherwood M; Murphy ML; Bingham AL; Siemianowski LA; Hunter K; Hollands JM
J Thromb Thrombolysis; 2017 May; 43(4):476-483. PubMed ID: 28070821
[TBL] [Abstract][Full Text] [Related]
67. Effect of body mass index on bleeding frequency and activated partial thromboplastin time in weight-based dosing of unfractionated heparin: a retrospective cohort study.
Bauer SR; Ou NN; Dreesman BJ; Armon JJ; Anderson JA; Cha SS; Oyen LJ
Mayo Clin Proc; 2009 Dec; 84(12):1073-8. PubMed ID: 19955244
[TBL] [Abstract][Full Text] [Related]
68. Strategies for managing heparin therapy in patients with antiphospholipid antibody syndrome.
Mehta TP; Smythe MA; Mattson JC
Pharmacotherapy; 2011 Dec; 31(12):1221-31. PubMed ID: 22122183
[TBL] [Abstract][Full Text] [Related]
69. A randomized comparative study of using enoxaparin instead of unfractionated heparin in the intervention treatment of coronary heart disease.
Chen JL; Chen J; Qiao SB; Guo YL; Wu YJ; Dai J; Yuan JQ; Qin XW; Yang YJ; Gao RL
Chin Med J (Engl); 2006 Mar; 119(5):355-9. PubMed ID: 16542576
[TBL] [Abstract][Full Text] [Related]
70. Weight-based heparin protocol using antifactor Xa monitoring.
Smith ML; Wheeler KE
Am J Health Syst Pharm; 2010 Mar; 67(5):371-4. PubMed ID: 20172987
[TBL] [Abstract][Full Text] [Related]
71. Age is a determinant factor for measures of concentration and effect in children requiring unfractionated heparin.
Newall F; Ignjatovic V; Johnston L; Summerhayes R; Lane G; Cranswick N; Monagle P
Thromb Haemost; 2010 May; 103(5):1085-90. PubMed ID: 20174762
[TBL] [Abstract][Full Text] [Related]
72. Unfractionated heparin infusion for thromboprophylaxis in highest risk gastric bypass surgery.
F Shepherd M; Rosborough TK; Schwartz ML
Obes Surg; 2004 May; 14(5):601-5. PubMed ID: 15186625
[TBL] [Abstract][Full Text] [Related]
73. Unfractionated heparin dosing in young infants: clinical outcomes in a cohort monitored with anti-factor Xa levels.
Schechter T; Finkelstein Y; Ali M; Kahr WH; Williams S; Chan AK; Deveber G; Brandão LR
J Thromb Haemost; 2012 Mar; 10(3):368-74. PubMed ID: 22244010
[TBL] [Abstract][Full Text] [Related]
74. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
Taneja R; Marwaha G; Sinha P; Quantz M; Stitt L; Gao R; Subramanian S; Schaus M; Keeney M; Chin-Yee I; Murkin J
Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
[TBL] [Abstract][Full Text] [Related]
75. Enoxaparin versus unfractioned heparin as anticoagulant for continuous venovenous hemodialysis: a randomized open-label trial.
Garcés EO; Victorino JA; Thomé FS; Röhsig LM; Dornelles E; Louzada M; Stifft J; de Holanda F; Veronese FV
Ren Fail; 2010 Jan; 32(3):320-7. PubMed ID: 20370447
[TBL] [Abstract][Full Text] [Related]
76. Effect of Subcutaneous Unfractionated Heparin Prophylaxis on Activated Partial Thromboplastin Time: A Retrospective Evaluation.
Thompson MH; Wilson SH; Toussaint BL; Jordan CL; Hayes GL; McKinzie BP; Wolf BJ; Field LC
J Clin Anesth; 2016 Sep; 33():346-50. PubMed ID: 27555191
[TBL] [Abstract][Full Text] [Related]
77. Developing an Anti-Xa-Based Anticoagulation Protocol for Patients with Percutaneous Ventricular Assist Devices.
Sieg A; Mardis BA; Mardis CR; Huber MR; New JP; Meadows HB; Cook JL; Toole JM; Uber WE
ASAIO J; 2015; 61(5):502-8. PubMed ID: 26273933
[TBL] [Abstract][Full Text] [Related]
78. Design and Implementation of an Anti-Factor Xa Heparin Monitoring Protocol.
Williams-Norwood T; Caswell M; Milner B; Vescera JC; Prymicz K; Ciszak AG; Ingle C; Lacey C; Stavrou EX
AACN Adv Crit Care; 2020 Jun; 31(2):129-137. PubMed ID: 32526007
[TBL] [Abstract][Full Text] [Related]
79. Adding intravenous unfractionated heparin to standard enoxaparin causes excessive anticoagulation not detected by activated clotting time: results of the STACK-on to ENOXaparin (STACKENOX) study.
Drouet L; Bal dit Sollier C; Martin J
Am Heart J; 2009 Aug; 158(2):177-84. PubMed ID: 19619692
[TBL] [Abstract][Full Text] [Related]
80. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
